Publications by authors named "Jonathan Pak"

Claim this Profile
C
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial.
Adam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, Monica Leyva, Laura Webb, Jonathan Pak

Am J Prev Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the selection of an SGLT2i vs. a GLP-1RA as cardioprotective agent in patients with type 2 diabetes.
Shubham Agarwal, Mujeeb A Basit, Michael E Bowen, Daniel F Heitjan, Christine Mai, Jonathan Pak

Front Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
Adam J Nelson, Lisa A Kaltenbach, Darren K McGuire, Monica Levya, Hussein R Al-Khalidi, Jonathan Pak

Am Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings.
Aaron S Kelly, Melanie Bahlke, Jennifer L Baker, Carine de Beaufort, Ruth M Belin, Jonathan Pak

Pediatr Obes· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
Manasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, Darren K McGuire, Vanita R Aroda, Jonathan Pak

Circulation· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and Clinical Outcomes of Infections: A Six-Year Retrospective Study.
Akram Khan, Hamza Alzghoul, Abdul Ahad Khan, Gopal Allada, Juliann M Gronquist, Jonathan Pak

Medicina (Kaunas)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of selexipag, a prostacyclin receptor analog, for treatment of severe pulmonary artery hypertension during pregnancy, a case report.
Akram Khan, Kinsley Hubel, Kathleen Brookfield, Jonathan Pak, Gopal Allada

Respir Med Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
Neha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, Monica Leyva, Darren K McGuire, Jonathan Pak

JAMA· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.
Adam J Nelson, Neha J Pagidipati, Michelle D Kelsey, Maddalena Ardissino, Vanita R Aroda, Jonathan Pak

Am Heart J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.
Adam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, Jennifer B Green, Renato D Lopes, Jonathan Pak

JAMA Netw Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
Adam J Nelson, Neha J Pagidipati, Vanita R Aroda, Matthew A Cavender, Jennifer B Green, Jonathan Pak

Circulation· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey.
Nathan D Wong, Wenjun Fan, Jonathan Pak

Diab Vasc Dis Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Care Physicians' Knowledge of the Cardiovascular Effects of Diabetes Medications: Findings from an Online Survey.
Jay H Shubrook, Jonathan Pak, George Dailey

Adv Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Type 2 Diabetes and Cardiovascular Disease: The "For Your SweetHeart™" Survey.
Leigh Perreault, Marilyn K Boardman, Jonathan Pak

Adv Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
John J DiGiovanna, Craig B Langman, Eduardo H Tschen, Terry Jones, Alan Menter, Jonathan Pak

J Am Acad Dermatol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of scopolamine in older rabbits tested in the 750 ms delay eyeblink classical conditioning procedure.
Diana S Woodruff-Pak, John T Green, Jonathan T Pak, Boris Heifets, Michelle H Pak

Integr Physiol Behav Sci· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term effects of nefiracetam on learning in older rabbits.
Diana S Woodruff-Pak, John T Green, Jonathan T Pak, Tadashi Shiotani, Shigeo Watabe

Behav Brain Res· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nefiracetam ameliorates associative learning impairment in the scopolamine-injected older rabbit.
Jonathan Pak, John Green, Boris Heifets, Michelle Pak, Diana Woodruff-Pak

Med Sci Monit· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis